Senior Scientist
Department of Drug discovery
Freiburg
Germany
Tel: +49-0-30-40-39-47-18
Dr. Khalid Abu Ajaj is a Senior Scientist in Department of Drug discovery in Freiburg, Germany. Dr. Abu Ajaj is a highly motivated and experienced R&D chemist in Pharmaceutical chemistry and Drug targeting in Oncology with an extensive experience in Preparative Organic synthetic chemistry in a wide range of chemical fields. (Pro drugs, Carbohydrates, Heterocycles, Peptides, Cross-linkers, Compound libraries for screening studies) as well as in the techniques of advanced Organic synthesis (Automated Solid-phase, Parallel synthesis Microwave-assisted synthesis, SPOT-synthesis of compound libraries), and Processing skills in Analytical methods (HPLC), Interpretation of spectra (NMR, MS, IR), and using databases (SciFinder) and scientific computer programs (MS Office, chemical software). Dr. Abu Ajaj research interests are Cancer chemotherapy, Drug targeting, Drug delivery systems in Oncology, Bio conjugate chemistry, Drug delivery systems in oncology, Prodrugs in oncology, Circumventing multidrug resistance, Receptor and Antigen targeting, Multifunctional-acting prodrugs, Tumor-associated protease. Dr. Abu Ajaj research activities are also include many publications in peer-reviewed journals, Abstracts and book chapter, Co-inventor of different patents and patent applications, Participation in different international conferences, Symposia and und workshops.
